Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Abstract: This paper investigates fixed-time prescribed performance control issue of vehicular platoon subject to input nonlinearities induced by actuator dead-zone ...
April 22, 2026 • President Trump says the Kennedy Center must close for renovation. Members of Congress and two lawsuits contend the real reason is mismanagement, artist cancellations and declining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results